Trending now
President TrumpAuschwitzRepublicans Senate AmericansRoger StoneFauci Trump White HousePresident Biden WednesdayPhyllis LindstromLeachman Emmy AwardsPresident Donald TrumpHouse Minority Leader Kevin McCarthyAmanda GormanApple AmericanWhite House National ClimateMichigan Governor Gretchen WhitmerJanuaryBoysArizona Republican PartySouth African Covid-19Leachman won Emmy AwardsPhyllisResults for
Results for
Create your own feed
The large colchicine RCT for covid is preprint published. It shows some consistent directional benefit for major outcomes Since this is a pill, it's safe, cheap & an early intervention (as tested here, before hospital) these findings are very encouraging
Share
The paper on colchicine + Covid has dropped. It's a bit on the low side of what was described. P value on primary is 0.08; on secondary is 0.04. Would love to hear people's thoughts here. Or feel free to email/DM.
The government may conduct clinical trials for colchicine, a drug for gout that has reportedly shown efficacy in treating Covid-19 in Canada. | @JMAurelioINQ
The preprint of COLCORONA trial results is just out. OR 0.79 p=0.08 ITT on risk of death or hospitalization, 0.75 p=0.04 in PCR-confirmed Efficacy of Colchicine in Non-Hospitalized Patients with COVID-19
ColCORONA: Oral, anti-inflammatory drug colchicine reduces complications in outpatient COVID.
The government may allow clinical trials for colchicine, a drug believed to be effective for treating Covid-19, Health Chief Francisco Duque III said Wednesday. | @CMarquezINQ
@JMAurelioINQ Vergeire warns the public vs self-medicating against COVID-19 using colchicine, says DOH has not yet issued guidelines on the possible use of colchicine vs the illness. She says colchicine should only be used under supervision of doctor. | @JMAurelioINQ
COVID-19: Montreal Heart Institute concludes colchicine tablet is effective
The gout medicine colchicine may significantly reduce the risk of #coronavirus patients requiring hospital treatment, a new study shows.
Health experts green-light colchicine for treating outpatient Covid-19
Loading
A study from Quebec suggests that colchicine, a cheap and widely available drug, can reduce the risk of serious illness from COVID-19. @CTV_AvisFavaro reports:
Colchicine for covid? A large (>4,000 patients) placebo-controlled, randomized trial of early, out-patient oral treatment suggests benefit, but limited data via press release tonight (need to see more) via @matthewherper
A gout drug shows promise for Covid-19, but skeptics worry about trusting science by press release. My take on the colchicine results: amazing if true, but we need to see a lot more of the data, and may need other studies.
In a randomized, placebo-controlled trial of 4745 patients with recent myocardial infarction, low-dose colchicine (0.5 mg once daily) prevented ischemic cardiovascular events. See the COLCOT trial. #AHA19
Original Article: Colchicine in Patients with Chronic Coronary Disease (LoDoCo2 Trial) #ESCCongress
Patients with chronic coronary disease were randomized to daily colchicine or placebo. Incidence of the composite endpoint of cardiovascular death, spontaneous MI, ischemic stroke, or ischemia-driven coronary revascularization was significantly lower with colchicine. #ESCCongress
Research in Nature uncovers the plant biosynthesis of colchicine, a drug used for inflammatory disorders since Ancient Egypt.
In a randomized, placebo-controlled trial involving 4745 patients with recent myocardial infarction, low-dose colchicine (0.5 mg once daily) prevented ischemic cardiovascular events.
Original Article: Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Loading